Medical Patent News

RSS

USPTO issues patent for Predictive Biosciences' multiple biomarker assay

Predictive Biosciences, a provider of novel molecular diagnostic tests, announced that on June 7, 2011 the U.S. Patent and Trademark Office issued Patent Number 7,955,822 for "Detection of Nucleic Acids and Proteins".

17 Jun 2011

DiagnoCure receives new U.S. patent for PCA3 prostate cancer biomarker portfolio

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported the issuance of a new U.S. patent, which represents a significant addition to DiagnoCure's PCA3 prostate cancer biomarker portfolio.

16 Jun 2011

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announced today that it has filed for patent protection covering a novel antibody product for Age-related Macular Degeneration (AMD) and other eye disorders.

16 Jun 2011

USPTO issues patent to EndoSphere's noninvasive device for treatment of obesity

EndoSphere Inc., a medical technology company that holds 23 U.S. and international issued and pending patents, announced today that the U.S. Patent and Trademark Office has issued the company a patent covering the use of its endoscopically implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes.

16 Jun 2011

USPTO upholds ten amended claims of SANUWAVE's '119 patent

SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in regenerative medicine, today reported that the U.S. Patent and Trademark Office (USPTO) issued a reexamination certificate upholding ten amended claims of SANUWAVE's U.S. Patent No. 6,080,119 following a third party's ex parte reexamination request.

15 Jun 2011

Galectin strengthens cancer drug patent portfolio in Europe

Galectin Therapeutics Inc. today announced that the European Patent Office has granted the Company a new patent, No. 02731178.6, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer".

15 Jun 2011

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.

15 Jun 2011

AJ, ATCC sign worldwide non-exclusive licensing agreement for iPS cell patent portfolio

ATCC, the premier biological materials resource and standards organization, and iPS Academia Japan, Inc. (Kyoto, Japan) (AJ) today announced a worldwide non-exclusive licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.

15 Jun 2011

University of Mississippi grants ChromaDex global rights to pterostilbene

ChromaDex Corp. and the University of Mississippi today announced the university has granted the natural products company the exclusive worldwide patent rights to a potential new therapeutic use for pterostilbene (tero-STILL-bean) as an anxiolytic or anti-anxiety agent. ChromaDex' pTeroPure® is an ultra-pure formulation of pterostilbene, a compound found in blueberries and demonstrated to have multiple health benefits.

9 Jun 2011

Covidien files answer and counterclaims against Applied Medical for patent misuse, non-infringement

Covidien, a leading global provider of healthcare products, today announced that a subsidiary of the Company filed an answer and counterclaims against Applied Medical Resources Corporation for patent misuse, non-infringement and invalidity.

8 Jun 2011

U.S. District Court rules in favor of Boston Scientific in PROMUS patent lawsuit

Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.

8 Jun 2011

Incisive Surgical receives U.S. patent for INSORB Absorbable Skin Stapling Technology

Incisive Surgical, Inc. today announced that the U.S. Patent and Trademark Office (USPTO) issued the Company a key patent for its proprietary INSORB Absorbable Skin Stapling Technology.

7 Jun 2011

Patent infringement suit filed against Impax Laboratories in connection with Detrol

Impax Laboratories, Inc. today confirms that Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB have filed suit for patent infringement against Impax in the United States District Court for the District of New Jersey in connection with Detrol (tolterodine tartrate) immediate-release, 1 mg and 2 mg tablets.

4 Jun 2011

Medisafe 1 Technologies to submit three patent applications for medical devices

Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company is in the process of submitting three patent applications for medical safety devices.

4 Jun 2011

Syndax receives U.S. patent for entinostat to treat metastatic cancers

Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the United States Patent and Trademark Office of Patent Application Serial No. 12/549458 entitled: " N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL)- METHOXYCARBONYL—AMINOMETHYL]-BENZAMINE (MS-275) POLYMORPH B."

3 Jun 2011

Rheonix to receive U.S. patent for powerful microfluidic platform

Rheonix, Inc., developer of the Rheonix CARD system that provides a powerful microfluidic platform for the evolving molecular diagnostics industry, announced that on June 14, 2011 the U.S. Patent and Trademark Office will issue Patent Number 7,959,875, "Microfluidic Chips and Assay Systems," and on April 13, 2011 it allowed Patent Application Number 11/594,444, "Microfluidic Systems," to the Company.

3 Jun 2011

Anadys receives U.S. patent for setrobuvir to treat chronic hepatitis C

Anadys Pharmaceuticals, Inc. today announced issuance of the U.S. patent covering setrobuvir, the Company's Direct-Acting Antiviral in Phase IIb development for chronic hepatitis C virus infection.

2 Jun 2011

EPO awards Trilink patent for CleanAmp Primers

TriLink BioTechnologies, Inc., a leader in manufacturing high quality oligonucleotides and nucleoside triphosphates, announced today the award of their CleanAmp Primer patent by the European Patent Office (EPO Patent no. 2032714).

27 May 2011

Key U.S. patents increase commercial rights and clinical indications

Australian regenerative medicine company, Mesoblast Limited (ASX:MSB; OTC ADR: MBLTY), today announced that the company’s product development strategy has been significantly strengthened by novel composition of matter claims granted by the United States Patent and Trade Mark Office (USPTO) in two distinct patent families to which Mesoblast has exclusive worldwide commercial rights.

23 May 2011

Prowess files patent infringement lawsuit against RaySearch in Baltimore court

As previously announced, RaySearch Laboratories AB has been contacted by a US company named Prowess, which claims that RaySearch has infringed on a US patent in respect of which Prowess has a license.

23 May 2011

Medical Patent News

USPTO issues patent for Predictive Biosciences' multiple biomarker assay

DiagnoCure receives new U.S. patent for PCA3 prostate cancer biomarker portfolio

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

USPTO issues patent to EndoSphere's noninvasive device for treatment of obesity

USPTO upholds ten amended claims of SANUWAVE's '119 patent

Galectin strengthens cancer drug patent portfolio in Europe

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

AJ, ATCC sign worldwide non-exclusive licensing agreement for iPS cell patent portfolio

University of Mississippi grants ChromaDex global rights to pterostilbene

Covidien files answer and counterclaims against Applied Medical for patent misuse, non-infringement

U.S. District Court rules in favor of Boston Scientific in PROMUS patent lawsuit

Incisive Surgical receives U.S. patent for INSORB Absorbable Skin Stapling Technology

Patent infringement suit filed against Impax Laboratories in connection with Detrol

Medisafe 1 Technologies to submit three patent applications for medical devices

Syndax receives U.S. patent for entinostat to treat metastatic cancers

Rheonix to receive U.S. patent for powerful microfluidic platform

Anadys receives U.S. patent for setrobuvir to treat chronic hepatitis C

EPO awards Trilink patent for CleanAmp Primers

Key U.S. patents increase commercial rights and clinical indications

Prowess files patent infringement lawsuit against RaySearch in Baltimore court

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News